Cresset Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31K | Buy |
23,508
+553
| +2% | +$989 | ﹤0.01% | 1591 |
|
|
2025
Q4 | $42.9K | Hold |
22,955
| – | – | ﹤0.01% | 1620 |
|
|
2025
Q3 | $29.4K | Hold |
22,955
| – | – | ﹤0.01% | 1546 |
|
|
2025
Q2 | $28.5K | Hold |
22,955
| – | – | ﹤0.01% | 1404 |
|
|
2025
Q1 | $27.1K | Sell |
22,955
-2,928
| -11% | -$4.49K | ﹤0.01% | 1679 |
|
|
2024
Q4 | $47.4K | Sell |
25,883
-40,890
| -61% | -$79.8K | ﹤0.01% | 1672 |
|
|
2024
Q3 | $114K | Sell |
66,773
-2,280
| -3% | -$3.75K | ﹤0.01% | 2036 |
|
|
2024
Q2 | $94.6K | Sell |
69,053
-9,857
| -12% | -$19.9K | ﹤0.01% | 1958 |
|
|
2024
Q1 | $296K | Buy |
78,910
+15,688
| +25% | +$91.9K | ﹤0.01% | 1591 |
|
|
2023
Q4 | $620K | Buy |
63,222
+6,153
| +11% | +$50.3K | ﹤0.01% | 1112 |
|
|
2023
Q3 | $477K | Buy |
57,069
+6,125
| +12% | +$70K | ﹤0.01% | 1207 |
|
|
2023
Q2 | $678K | Buy |
+50,944
| New | +$619K | ﹤0.01% | 1119 |
|
|
2022
Q4 | – | Sell |
-48,405
| Closed | -$281K | – | 843 |
|
|
2022
Q3 | $281K | Sell |
48,405
-339
| -0.7% | -$1.95K | ﹤0.01% | 688 |
|
|
2022
Q2 | $214K | Buy |
48,744
+687
| +1% | +$4.17K | ﹤0.01% | 821 |
|
|
2022
Q1 | $437K | Sell |
48,057
-2,932
| -6% | -$33.8K | ﹤0.01% | 641 |
|
|
2021
Q4 | $1.04M | Sell |
50,989
-16,118
| -24% | -$389K | 0.01% | 442 |
|
|
2021
Q3 | $1.72M | Buy |
67,107
+250
| +0.4% | +$7.41K | 0.02% | 256 |
|
|
2021
Q2 | $2.34M | Buy |
66,857
+524
| +0.8% | +$15.2K | 0.03% | 181 |
|
|
2021
Q1 | $2.21M | Buy |
+66,333
| New | +$2.32M | 0.04% | 166 |
|
|
2020
Q4 | – | Sell |
-32,000
| Closed | -$316K | – | 797 |
|
|
2020
Q3 | $316K | Buy |
+32,000
| New | +$184K | 0.01% | 497 |
|
Other funds holding PACB
AIM
VCM
NAMA
